Drug Topics
NOVEMBER 7, 2023
A Q&A with Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies, about different strategies pharmacies can use to bring in new customers.
PharmaVoice
NOVEMBER 9, 2023
A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics can mute sickle cell disease’s most damaging symptoms. Yet treatment may not be as simple as its dramatic benefit makes it seem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 6, 2023
AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.
STAT
NOVEMBER 10, 2023
Pharmacies were once abundant in the South Side of Chicago. Now, residents living in the majority Black neighborhood often find themselves with few options when it’s time to get a prescription refilled or stock up on cold medicine. Ladell Johnson, a longtime resident of the South Side, drives half an hour from her house to the downtown area every time she needs to pick up her prescription.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 6, 2023
Although long COVID has emerged as a major public health concern, it has not yet been clearly identified as a clinical condition.
PharmaVoice
NOVEMBER 6, 2023
Bioethics guru Arthur Caplan of NYU gives his outspoken and frank opinion on the industry’s minefield of ethical challenges.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 9, 2023
In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.
Drug Topics
NOVEMBER 8, 2023
The drug, Zepbound, will be available in the United States by the end of 2023.
PharmaVoice
NOVEMBER 9, 2023
The maze of ethical issues in biopharma can confound even the wiliest executive. How do some leaders get by?
Pharmacy Times
NOVEMBER 8, 2023
Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the emergence of gene therapy as an exciting option for patients with hemophilia A and highlight benefits, limitations, and ongoing research in the field.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 10, 2023
An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. If adopted, the U.K. would be the first country to use the meningitis B vaccine for this purpose. The Joint Committee on Vaccination and Immunization released a report Friday saying that targeted use of a meningitis B vaccine — GSK’s Bexsero — in people at high risk of contracting gonorrhea should reduce the inci
Drug Topics
NOVEMBER 6, 2023
Unlike traditional THC, which is federally banned, D8 has managed to find a legal loophole, making it widely accessible.
PharmaVoice
NOVEMBER 8, 2023
A new way to administer vaccines at home could help AstraZeneca reach a wider market for FluMist, the nasal influenza vaccine.
Pharmacy Times
NOVEMBER 7, 2023
AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 8, 2023
Vaccines work well to prevent cancers caused by the human papillomavirus (HPV). So well, in fact, that it may be time to review HPV screening protocols, according to the somewhat provocative conclusion of a new study examining the occurrence of genital HPV types eight years after immunization, published today in Cell Host & Microbe. The randomized control study included more than 60,000 women from 33 Finnish communities born in 1992, 1993, and 1994.
Drug Topics
NOVEMBER 10, 2023
Ixchiq contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
PharmaVoice
NOVEMBER 8, 2023
With an AOC platform targeting muscle diseases, Avidity Biosciences hopes to break open the possibilities of RNA.
Pharmacy Times
NOVEMBER 6, 2023
Children with a score of higher than 30 on the CHALF Score scale will need an emergency transplant.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
NOVEMBER 7, 2023
The number of babies born with congenital syphilis in the United States has soared over the last decade, leading to an increase in stillbirths, infant deaths, and life-altering birth defects, the Centers for Disease Control and Prevention reported Tuesday. The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequa
Drug Topics
NOVEMBER 8, 2023
A study found that a pharmacist-prescribing intervention for high blood pressure could save the health care system $1.137 trillion over a 30-year period.
The Guardian - Pharmaceutical Industry
NOVEMBER 7, 2023
Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.
Pharmacy Times
NOVEMBER 4, 2023
Understanding the mechanisms leading to weight loss could help identify potential benefits for cardiorenal health in patients with chronic kidney disease.
STAT
NOVEMBER 7, 2023
More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin. In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts , who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.
Drug Topics
NOVEMBER 9, 2023
Mebella is another weapon in the global fight to eradicate these diseases.
Fierce Healthcare
NOVEMBER 5, 2023
Family physicians utilizing value-based payment (VBP) models reported burnout relief in a new study from EHR com | The study found that higher capitation rates combined with greater overall percentage of revenue from capitation resulted in the biggest reduction in physician burnout.
Pharmacy Times
NOVEMBER 8, 2023
Tirzepatide is already approved under the brand name Mounjaro (Lilly) to be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
STAT
NOVEMBER 8, 2023
Eli Lilly’s blockbuster drug tirzepatide, sold as Mounjaro for type 2 diabetes, has been cleared to treat obesity, making it the second in a highly effective class of weight loss medications to enter the market. The Food and Drug Administration’s long-awaited approval of the drug, which will be marketed under the name Zepbound for obesity, is a major milestone for Lilly.
Drug Topics
NOVEMBER 9, 2023
The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.
BioPharm
NOVEMBER 6, 2023
The Alliance for mRNA Medicines (AMM) was officially launched at the 11th International mRNA Health Conference in Berlin, Germany.
Pharmacy Times
NOVEMBER 9, 2023
Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.
STAT
NOVEMBER 7, 2023
Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s office after a nearly two-year effort to install a permanent leader atop the $48 billion science agency. The Senate voted 62-36 Tuesday to confirm her nomination, giving the White House clearance to officially name Bertagnolli the institute’s director, the second woman ever to fill the role.
Drug Topics
NOVEMBER 10, 2023
Ixchiq was approved through the FDA Accelerated Approval pathway.
Fierce Healthcare
NOVEMBER 8, 2023
Legislative spotlight was put back on pharmacy benefit manager reform and mental health in a comprehensive draft packaged presented by the Senate Finance Committee, which was passed Wednesday 26-0. | A comprehensive healthcare package garnered near unanimous approval on Wednesday, which could lead to big changes for PBMs down the road.
Expert insights. Personalized for you.
528 
Let's personalize your content